95375 ā
Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
COMPOUNDS FOR REDUCING CHOLESTEROL AND TREATING LIVER AND KIDNEY DISEASE
#2NOVEL COCRYSTALS OF METHYLXANTHINES, THEIR POLYMORPHS AND PROCESS THEREOF
#3COMPOUNDS FOR MODULATING HUR (ELAVL1)
#4CYCLIC AMIDE-CONTAINING PYRIDYL XANTHINES AS A2B ANTAGONISTS
#5THEOPHYLLINE-LOADED COLLAGEN NANOPARTICLES
#6NOVEL KINASE MODULATORS
#7Cyclic amide-containing pyridyl xanthines as AB antagonists
#8POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) INHIBITORS AGAINST COVID MACRODOMAIN AND METHODS OF USING THE SAME
#9SMALL MOLECULE CB002-ANALOGES RESTORE THE P53 PATHWAY AND TARGET S-PHASE CHECKPOINT
#10PURINE DIONES AS WNT PATHWAY MODULATORS
#11Cyclic amide-containing pyridyl xanthines as Aantagonists
#12THEOPHYLLINE DERIVATIVES WITH NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND RELATIVE USE
#13Compounds For Repressing Cancer Cell Growth
#14SPECIFICALLY-SHAPED CRYSTAL OF COMPOUND AND METHOD FOR PRODUCING SAME
#15SPECIFICALLY-SHAPED CRYSTAL OF COMPOUND AND METHOD FOR PRODUCING SAME
#16Purine diones as Wnt pathway modulators
#17NOVEL FUNCTIONALIZED PURINE-2,6-DIONES AND THEIR USE IN MEDICINE
#18Microbiocidal oxadiazole derivatives
#19Xanthine analogs as potent anti-West Nile viral agents
#20Kinase modulators
#21Purine diones as Wnt pathway modulators
#22Oxadiazole transient receptor potential channel inhibitors
#23Inhibiting the transient receptor potential A1 ion channel
#24Microbiocidal oxadiazole derivatives
#25NOVEL MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL AND METHODS FOR TREATMENT OF NON-SMALL CELL LUNG CANCER
#26Compounds for repressing cancer cell growth
#27THEOBROMINE COMPOSITIONS USEFUL FOR INCREASING FETAL WEIGHT GAIN AND ENHANCING BONE PROPERTIES
#288-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
#29Inhibiting the transient receptor potential A1 ion channel
#30Purine diones as Wnt pathway modulators
#31Anti-ice nucleation activator
#32Methods and compositions for treating pain
#338-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
#34Purine diones as Wnt pathway modulators
#35Prevention or treatment of uratic or gouty diseases
#36Compounds for the treatment of myotonic dystrophy
#37Inhibiting the transient receptor potential A1 ion channel
#38INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL
#39Kinase modulators
#40Deuterated compounds useful for treating neurodegenerative diseases
#418-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions
#42SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
#43Purine diones as Wnt pathway modulators
#44Composition useful for treating disorders related to TRPA1
#45Theobromine compositions useful for increasing fetal weight gain and enhancing bone properties
#46Flagellar and needle complex (injectosome) loop as anti bacterial drug target
#47Small molecule bicyclic and tricyclic CFTR correctors
#488-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
#49Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
#50Process for the preparation of acebrophylline
#51Xanthine derivative
#52Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
#53SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
#54Methods and compositions for treating pain
#55Inhibiting the transient receptor potential A1 ion channel
#56Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies
#57COMPOSITIONS WITH INCREASED STABILITY FOR INHIBITING TRANSIENT RECEPTOR POTENTIAL ION CHANNEL TRPA1
#58INHIBITING TRPA1 FOR THE TREATMENT OF ASTHMA
#59Azolium and purinium salt anticancer and antimicrobial agents
#608-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
#61NEUROTROPHIN MIMETICS AND USES THEREOF
#62SERMs for the treatment of estrogen receptor-mediated disorders
#63XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
#64Method for producing complex crystal and method for screening complex crystal
#65Compositions useful for treating disorders related to TRPA1
#66Inhibitors of p75 receptor and their uses
#67MULTI-MODALITY MOLECULAR IMAGING HIGH-THROUGHPUT ASSAY FOR IDENTIFYING HEAT SHOCK PROTEIN 90 (HSP90) INHIBITORS
#68Use of TRPA1 antagonists to prevent or treat infections caused by biological-warfare agents
#69Antiviral drugs for treatment or prevention of dengue infection
#70Inhibiting transient receptor potential ion channel TRPA1
#71USE OF DPAS AND CO-POLYMERS FOR HYPERLIPIDEMIA AND ATHEROSCLEROSIS ALONG WITH REDUCING FEEDING RATE AND ADIPOSE TISSUE WEIGHT OF OBESITY ANIMAL
#72XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
#73DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS
#74Methods and compositions for treating pain
#75METHODS AND COMPOSITIONS FOR TREATING DISORDERS
#76Azo compound, azo pigment, pigment dispersion, coloring composition, color filter, ink for inkjet recording, and printing ink
#77DEUTERATED COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISEASES
#78Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
#79Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
#80USE FOR IMPROVING 5-HT FUNCTION AND ENOS EXPRESSION OF KMUPS AMINE SALTS
#818-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
#82Process for preparing heteroaromatic ring compound having N-Rf group
#83Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
#84USE OF KMUP-3 FOR MYOCARDIAL INFARCTION
#854H-chromen-4-one compounds as modulators of protein kinases
#86Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
#87Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
#88NEUROTROPHIN MIMETICS AND USES THEREOF
#89Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
#90Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
#91DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS
#92Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
#93HALOGENATED XANTHINE DERIVATIVES AND PRECURSORS THEREOF FOR ANTI-CANCER AND ANTI-METASTASIS ACTIVITY AND PREPARING METHOD THEREOF
#942,3-disubstituted chromen-4-one compounds as modulators of protein kinases
#95Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
#96SPECIFIC INHIBITORS FOR VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS
#97Methods and compositions for treating asthma
#98XANTHINE-BASED CYCLIC GMP-ENHANCING RHO-KINASE INHIBITOR INHIBITS PHYSIOLOGICAL ACTIVITIES OF LUNG EPITHELIAL CELL LINE
#99SYNTHESIS AND PHARMACOKINETIC ACTIVITIES OF PULMODIL AND PULMODIL-1, TWO CHLOROPHENYLPIPERAZINE SALT DERIVATIVES
#100SUBSTITUTED 8-HETEROARYL XANTHINES
#101Methods and compositions for treating pain
#102Compositions useful for treating disorders related to TRPA1
#103Process for preparing heteroaromatic ring compound having N-Rf group
#104Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
#105Antiviral drugs for treatment or prevention of dengue infection
#106Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
#107SUBSTITUTED XANTHINE COMPOUNDS
#108XANTHINE-BASED CYCLIC GMP-ENHANCING RHO-KINASE INHIBITOR INHIBITS PHYSIOLOGICAL ACTIVITIES OF LUNG EPITHELIAL CELL LINE
#109Heterocyclic compounds as adenosine receptor antagonist
#110ANTI-INFLAMMATION ACTIVITY OF NEWLY SYNTHESIZED XANTHINE DERIVATIVES KMUP-1 AND KMUP-3
#111Methods and compositions for treating disorders
#112A2B ADENOSINE RECEPTOR ANTAGONISTS
#113Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
#114Xanthine Derivatives, Processes For Preparing Them And Their Uses
#115A2B ADENOSINE RECEPTOR ANTAGONISTS
#1168-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
#1178-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
#118Substituted 8-heteroaryl xanthines
#119A2B ADENOSINE RECEPTOR ANTAGONISTS
#120Specific inhibitors for vascular endothelial growth factor receptors
#121BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS
#122ANTI-INFLAMMATION ACTIVITY OF NEWLY SYNTHESIZED XANTHINE DERIVATIVES KMUP-1 AND KMUP-3
#123Theophylline-based nitophenylpiperazine derivatives for enhancing aortic smooth muscle relaxation
#124Xanthine phosphodiesterase V inhibitors
#125Adenosine A2B receptor antagonists
#126Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV
#127Methods and compositions for treating pain
#128N,Nā²-substituted-1,3-diamino-2-hydroxypropane derivatives
#129Chemical compounds
#130Agents for treating migraine
#131Conjugates of mycophenolic acid
#132Aadenosine receptor antagonists
#133XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
#134Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
#1358-heteroaryl xanthine adenosine Areceptor antagonists
#136Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
#137Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
#138Theophylline-based soluble guanylyl cyclase activators KMUP-1 analogues enhanced cyclic GMP and K+ channel activities on rabbit corpus cavernosum smooth muscle and intercavernous pressure activities
#139Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase
#140Xanthine phosphodiesterase V inhibitors
#141Chemical compounds
#142Electrochemiluminescent assays
#143Aadenosine receptor antagonists
#144Xanthine phosphodiesterase V inhibitors
#145Substituted 8-heteroaryl xanthines
#146Aadenosine receptor antagonists
#147Benzimidazole-derivatives as factor Xa inhibitors
#148Conjugates of mycophenolic acid